About Sipai Wangluo
Sipai Wangluo is a company based in Beijing (China) founded in 2014 by Li Dayong. It operates as a B2B. Sipai Wangluo has raised $20 million across 2 funding rounds from investors including Eight Roads Ventures, F-Prime Capital and Ping An Ventures. Sipai Wangluo operates in a competitive market with competitors including GenomOncology, ONCOHOST, Geneseeq, Radialogica and Protyon, among others.
- Headquarter Beijing, China
- Founders Li Dayong
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$20 M (USD)
in 2 rounds
-
Latest Funding Round
$10 M (USD), Series B
Jun 02, 2016
-
Investors
Eight Roads Ventures
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sipai Wangluo
Sipai Wangluo has successfully raised a total of $20M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sipai Wangluo
Sipai Wangluo has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures, F-Prime Capital and Ping An Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Locked | Locked | Locked | |
|
Corporate-backed venture capital firm focused on retail tech, mobile tech, and multiple sectors
|
Locked | Locked | Locked |
Investor details for Sipai Wangluo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sipai Wangluo
Investment portfolio details for Sipai Wangluo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sipai Wangluo
Detailed financials for Sipai Wangluo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sipai Wangluo Comparisons
Peer comparison for Sipai Wangluo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sipai Wangluo
Sipai Wangluo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenomOncology, ONCOHOST, Geneseeq, Radialogica and Protyon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic data is transformed into actionable insights for precision medicine.
|
|
| Locked | Locked | Locked |
AI-based proteomic analysis for oncology therapy planning is offered.
|
|
| Locked | Locked | Locked |
Personalized cancer treatments are delivered using genomic RNA profiling.
|
|
| Locked | Locked | Locked |
Decision support tools for radiation oncology are provided to clinicians.
|
|
| Locked | Locked | Locked |
Cancer therapeutics development and training programs are provided.
|
Detailed competitors of Sipai Wangluo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sipai Wangluo
Complete news archive for Sipai Wangluo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sipai Wangluo
Sipai Wangluo was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Sipai Wangluo is headquartered in Beijing, China.
Sipai Wangluo is a funded company, having raised a total of $20M across 2 funding rounds to date.
Sipai Wangluo, backed by 20000000.0 from Eight Roads Ventures, F-Prime Capital, Ping An Ventures, focuses on providing healthcare solutions, oncology, big data analytics, and data aggregation. Delivers big data aggregation and analytics solutions for oncology. Driving innovation, growth, and excellence in its industry sectors.
Sipai Wangluo's top competitors include ONCOHOST, GenomOncology and Geneseeq.
Sipai Wangluo has 3 investors. Key investors include Eight Roads Ventures, F-Prime Capital, and Ping An Ventures.